sb 203580 has been researched along with alpha-tocopherol acetate in 1 studies
Studies (sb 203580) | Trials (sb 203580) | Recent Studies (post-2010) (sb 203580) | Studies (alpha-tocopherol acetate) | Trials (alpha-tocopherol acetate) | Recent Studies (post-2010) (alpha-tocopherol acetate) |
---|---|---|---|---|---|
3,489 | 4 | 1,137 | 18 | 0 | 12 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kato, E; Sasaki, Y; Takahashi, N | 1 |
1 other study(ies) available for sb 203580 and alpha-tocopherol acetate
Article | Year |
---|---|
Sodium dl-α-tocopheryl-6-O-phosphate inhibits PGE₂ production in keratinocytes induced by UVB, IL-1β and peroxidants.
Topics: alpha-Tocopherol; Anti-Inflammatory Agents; Blotting, Western; Cyclooxygenase 2; Dinoprostone; Humans; In Vitro Techniques; Interleukin-1beta; Keratinocytes; Oxidants; p38 Mitogen-Activated Protein Kinases; Radiation-Protective Agents; Real-Time Polymerase Chain Reaction; RNA, Messenger; Skin; Ultraviolet Rays | 2011 |